Back to top
more

Thermo Fisher Scientific (TMO)

(Real Time Quote from BATS)

$454.38 USD

454.38
833,265

+5.44 (1.21%)

Updated Aug 7, 2025 03:26 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth B Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 40% (147 out of 246)

Industry: Medical - Instruments

Zacks News

Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Zacks Equity Research

Thermo Fisher Abandons Gatan Deal in Want of European Nod

Thermo Fisher (TMO) and Roper will carry on with their current long-term supply agreement.

Zacks Equity Research

Why Is Thermo Fisher (TMO) Up 0.6% Since Last Earnings Report?

Thermo Fisher (TMO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Thermo Fisher Acquires GlaxoSmithKline's Drug Production Site

The latest acquisition aligns with Thermo Fisher's (TMO) strategy of enhancing capabilities of its Pharma Services through the right balance of capital investment, and merger and acquisition.

Zacks Equity Research

Is Thermo Fisher Scientific (TMO) Stock Outpacing Its Medical Peers This Year?

Is (TMO) Outperforming Other Medical Stocks This Year?

Zacks Equity Research

Thermo Fisher Scientific Sees Hammer Chart Pattern: Time to Buy?

Thermo Fisher Scientific Inc. (TMO) has been struggling lately, but the selling pressure may be coming to an end soon.

Zacks Equity Research

The Zacks Analyst Blog Highlights: Mastercard, PayPal, Thermo Fisher, Starbucks and Simon Property

The Zacks Analyst Blog Highlights: Mastercard, PayPal, Thermo Fisher, Starbucks and Simon Property

Mark Vickery headshot

Top Research Reports for Mastercard, PayPal & Thermo Fisher

Today's Research Daily features new research reports on 16 major stocks, including Mastercard (MA), PayPal (PYPL) and Thermo Fisher (TMO).

Zacks Equity Research

Zacks.com featured expert Kevin Matras highlights: Foot Locker, Thermo Fisher Scientific, SS&C Technologies, Columbia Sportswear and Comcast

Zacks.com featured expert Kevin Matras highlights: Foot Locker, Thermo Fisher Scientific, SS&C Technologies, Columbia Sportswear and Comcast

Zacks Equity Research

Thermo Fisher (TMO) Beats on Q1 Earnings, Raises '19 View

Thermo Fisher (TMO) reports strong Laboratory Products and Services performance, flaunting robust global demand.

Sweta Killa headshot

5 Top-Ranked Cheap Dividend Growth Stocks

While there are several dividend stocks that could provide capital appreciation, honing in on stocks with a history of dividend growth leads to a healthy portfolio with a greater scope of capital appreciation.

Zacks Equity Research

What's in Store for Tandem Diabetes' (TNDM) Q1 Earnings?

The roll-out of Tandem Diabetes' (TNDM) unique insulin pump platform viz. t:slim X2 with Basal-IQ technology is expected to drive the top line in first-quarter 2019.

Zacks Equity Research

Why Earnings Season Could Be Great for Thermo Fisher (TMO)

Thermo Fisher (TMO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Zacks Equity Research

TMO or ABMD: Which Is the Better Value Stock Right Now?

TMO vs. ABMD: Which Stock Is the Better Value Option?

Zacks Equity Research

Thermo Fisher (TMO) to Report Q1 Earnings: What's in Store?

Strong analytical instruments business, product portfolio expansion and prudent growth strategy are likely to support Thermo Fisher (TMO) in Q1. However, forex might act as a dampener.

Zacks Equity Research

Can Boston Scientific's (BSX) Steady Growth Aid Q1 Earnings?

We are optimistic about Boston Scientific's (BSX) IC business that will help maintain its impressive global growth trend in Q1 owing to an innovative portfolio and strong commercial teams.

Zacks Equity Research

Can Five Elements Drive Quest Diagnostics (DGX) Q1 Earnings?

Quest Diagnostics (DGX) seems in sync with its strategy to expedite growth and operational excellence.

Zacks Equity Research

Thermo Fisher Scientific (TMO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Thermo Fisher (TMO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Will Solid Consumables Drive Illumina's (ILMN) Q1 Earnings?

Despite ongoing customers' transition from HiSeq consumables to NovaSeq, Illumina's (ILMN) Q1 results are expected to gain from this high throughput suite.

Zacks Equity Research

Top Ranked Momentum Stocks to Buy for April 16th

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, April 16th

Zacks Equity Research

Can Medical Devices Strength Drive Abbott (ABT) Q1 Earnings?

Abbott (ABT) expects high single-digit growth in Medical Devices' sales in first-quarter 2019 and continued double-digit growth in certain sub-segments.

Zacks Equity Research

Will Abbott's (ABT) Steady Overall Growth Aid Q1 Earnings?

At the end of 2018, Abbott (ABT) posts some encouraging data, buoying investors' optimism on its Diabetes Care segment.

Zacks Equity Research

The Zacks Analyst Blog Highlights: Mastercard, Honeywell, Thermo Fisher, Cigna and Norfolk Southern

The Zacks Analyst Blog Highlights: Mastercard, Honeywell, Thermo Fisher, Cigna and Norfolk Southern

Zacks Equity Research

Zacks.com featured expert Kevin Matras highlights: SS&C Technologies, Thermo Fisher Scientific, Columbia Sportswear, Heidrick & Struggles International and Anthem

Zacks.com featured expert Kevin Matras highlights: SS &C Technologies, Thermo Fisher Scientific, Columbia Sportswear, Heidrick & Struggles International and Anthem

Zacks Equity Research

Thermo Fisher (TMO) Hits 52-Week High, Can the Run Continue?

Thermo Fisher (TMO) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Sweta Killa headshot

5 Top-Ranked Dividend Stocks That Ensure Solid Growth

Given a dovish Fed and bouts of market volatility, investors are in search of steady income with some aspect of growth.